SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

Reminder: April Orientation Classes Available

April 2, 2020 - SCI Communications

This is a reminder that Cancer 101 (ccto-0100), RECIST (ccto-0101), and Clinical Research 101 (ccto-0075) are optional orientation classes scheduled to occur this April 2020. CCTO staff are encouraged to enroll, however these classes are not mandatory unless otherwise instructed by your manager.

Clinical Research 101:

  • Date: Monday, April 6, 9:30-11am via Zoom
  • Teacher: Elizabeth Anderson
  • To sign up: Contact Amanda Sullivan and she can enroll you in STARS

Cancer 101:

  • Date: Thursday, April 23, 9-10:30am via Zoom
  • Teachers: Ami Okada and/or Rachel Freiberg
  • To sign up: Search in STARS for “CCTO” or “ccto-0100” and the available course will show up for you to enroll in

RECIST:

  • Date: Thursday, April 30, 2:30-4pm
  • Teachers: Ami Okada and/or Rachel Freiberg
  • To sign up: Search in STARS for “CCTO” or “ccto-0101” and the available course will show up for you to enroll in

Please note that we offer Cancer 101, RECIST, and Clinical Research 101 quarterly. If a class has low enrollment, it will be cancelled.

STARS questions can be directed to Amanda Sullivan. Thank you!

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • PRISM
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube